-
Mashup Score: 0Venatorx Pharmaceuticals is Developing Therapeutic Improvements to Fight Gram Negative Bacterial and Viral Infections - 3 year(s) ago
CEO Christopher Burns spoke about their investigational therapy pipeline, the long view perspective for the company, and how the federal government’s use of the nomenclature innovation might actually hinder incremental improvements in antibiotic development.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1National Academies Report: Timely Diagnostics can Facilitate New Antimicrobials, Better Stewardship - 3 year(s) ago
In the second installment discussing this report, the authors point out that the approval of new diagnostics can help facilitate better stewardship.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
In the second installment of our series on the @theNASEM report, we cover how improvements in diagnostic testing will advance #antibiotic use and combat #antibioticresistance #BeAntibioticsAware #USAAW21 #WAAW2021 https://t.co/bbB2wJ4X1B
-
-
Mashup Score: 0ANTIBIOTICS | Contagion Live - 3 year(s) ago
This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization, and analytics. Cookie Policy
Source: www.contagionlive.comCategories: Infectious Disease, Latest HeadlinesTweet-
Today marks the start of US Antibiotic Awareness Week and World Antimicrobial Awareness Week. We will be posting stories and interviews all week on this paramount topic. #BeAntibioticsAware #USAAW21 #WAAW2021 https://t.co/KceKVhafTv
-
Watch our interview with @VenatorxPharma CEO Christopher Burns as he discusses the value of true innovation around known mechanisms when developing #antibiotics. #BeAntibioticsAware #USAAW21 #WAAW2021 https://t.co/0wii2Vc8Hn